COMMUNIQUÉS West-GlobeNewswire

NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025
22/01/2025
Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive year Management [...]
HTM College Education: AAMI Sets New Standard
22/01/2025
First-ever standard for training biomedical, clinical engineers Arlington, Virginia, Jan. 22, 2025 (GLOBE NEWSWIRE) -- There are relatively few healthcare technology management (HTM) educational programs that align with [...]
Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
22/01/2025
Live webcast on Wednesday, January 29 th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company [...]
Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer
22/01/2025
January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage [...]
AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS
22/01/2025
Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFS The early-onset broad-spectrum antiviral effect of Ampligen has been [...]
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
22/01/2025
Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programs DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an [...]
Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment
22/01/2025
SARASOTA, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
Tiny Health Launches Index Predicting Child’s Gut Microbiome Age
22/01/2025
AUSTIN, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiny Health , a leader in at-home gut microbiome testing, today announced the launch of its Gut Maturation Index, an advanced machine learning tool that predicts a child’ [...]
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
22/01/2025
WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today [...]
Noom Introduces Free AI-Powered Personalized Health Report to Promote Living Better Longer
22/01/2025
New Body Age Prediction and Existing Body Composition Analysis Now Available to Everyone, Including Free Members of Noom NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company [...]
Spectral AI Provides Update to Investors
22/01/2025
DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”) , developer of the AI-driven DeepView ® System, which received Breakthrough Device Designation from the U.S. FDA in [...]
IMMvention Therapeutix Enters Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
22/01/2025
DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and [...]
DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production
22/01/2025
TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a leading provider of innovative technology solutions for the cleantech and life sciences [...]
Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain
22/01/2025
Pain marks the second therapeutic area for Cullgen’s lead protein degrader CG001419 SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company [...]
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
22/01/2025
DUBLIN, Ireland, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Sev Melkonian has [...]
NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With HeartFlow and Boone Heart Institute to Launch GAMEFILM Registry to Assess Heart Disease Risks in Retired Football Players
22/01/2025
Registry will use HeartFlow FFR CT and Plaque Analysis to help inform strategies for prevention, earlier detection and improved care for former NFL athletes at high risk for coronary artery disease MOUNTAIN VIEW, Calif [...]
CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025
21/01/2025
MINNEAPOLIS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative [...]
Kraig Biocraft Laboratories Secures $10 Million SEPA to Support Spider Silk Production Growth and Commercialization
21/01/2025
ANN ARBOR, Mich., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a leading developer of spider silk-based fibers, announces that it has secured $10 [...]
NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director
21/01/2025
TORONTO and HAIFA, Israel, Jan. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (“ NurExone ” or the “ Company ”), a developer of exosome-based therapies for regenerative [...]

Pages